- 返回 |
- HOME
- / News & Events
- / Company Activity
- / A week of new drug development highlights
In the field of anti-infective drugs, Jiangxi Jemincare Group and Shanghai Jemincare Pharmaceutical Company discovered new antifungal compounds. In the field of endocrine drugs, Gilead Sciences and LG Chemical have discovered novel KHK inhibitors; In the field of nervous system drugs, Orexia Therapeutics discovers a novel orexin OX-2 receptor agonist; In the field of antitumor drugs, Haisco Pharmaceutical Company, Jiangsu Hengrui Pharmaceutical Company and Shanghai Hengrui Pharmaceutical Company, Xi 'an Xintong Pharmaceutical Research and Development Company, Qilu Regor Therapeutics Company, Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company, Nerviano Medical Science Company, Hainan New anti-tumor compounds have been reported by Sparkle Therapeutics, Taizhou Yiteng Pharmaceutical and Humanwell Healthcare Group.
Anti-infective drugs:
Jiangxi Jemincare Group and Shanghai Jemincare Pharmaceutical Company discovered novel antifungal compounds
Endocrine drugs:
Gilead Sciences Discovers novel KHK inhibitors
LG Chemical discovers new KHK inhibitor
Nervous system Drugs:
Orexia Therapeutics discovers novel orexin OX-2 receptor agonist
Antitumor drugs:
Haisco Pharmaceuticals discovers novel PRMT5 inhibitors
Jiangsu Hengrui Pharmaceutical Company and Shanghai Hengrui Pharmaceutical Company discovered new tetrahydronaphthalene compounds
Xi 'an Xintong Pharmaceutical Research and Development Company discovered a novel dual inhibitor of BTK and JAK3
Qilu Regor Therapeutics discovers novel CDK2 inhibitors
New STING agonists were discovered by Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company
Nerviano Medical Sciences discovers novel CDC7 inhibitors
New FGFR2 inhibitors discovered by Sparkle Therapeutics, Hainan
Taizhou Yiteng Pharmaceutical Company discovered a new CDK7 inhibitor
Humanwell Healthcare Group Inc. discovers novel Mat2A inhibitors
Shanghai Aryl Pharmaceutical Company and Zhejiang Hisun Pharmaceutical Company discovered a novel GTPase KRAS inhibitor
(This article uses data from the cortellis database)
Official Applets
Follow Us
021-64541543
Room 705-707, Building 2, 245 Jiachuan Road, Xuhui District, Shanghai
9:00-17:30